他汀诱导的伴咽肌受累的自身免疫性坏死性肌病
本文报告一例经尸检证实的老年患者抗HMGCR坏死性肌病,主要累及咽肌,导致吞咽困难、肺炎并在发病3周内死亡。作者提示对疑似抗HMGCR肌病患者应筛查吞咽困难、检测抗体滴度并考虑及时免疫抑制治疗。
要点
- 他汀相关抗HMGCR肌病虽罕见但可致命,老年多病共存者需警惕。
- 该例以咽肌受累为主,表现为吞咽困难、肺炎,3周内死亡。
- 疑似病例应筛查吞咽困难、检测抗HMGCR抗体并尽早免疫抑制治疗。
核心结论
- 抗HMGCR坏死性肌病是他汀的严重不良反应,可主要累及咽肌并导致吞咽困难、肺炎和死亡。
研究设计与样本
- 本文为单例尸检证实的病例报告,患者为老年、多病共存且多重用药者。
主要发现
- 该老年患者抗HMGCR坏死性肌病主要累及咽肌,出现吞咽困难、肺炎,自发病至死亡不超过3周。
关键数值与推荐
- 对疑似抗HMGCR肌病患者应筛查吞咽困难、检测抗HMGCR抗体滴度,并考虑及时免疫抑制治疗。
临床怎么用
- 老年多病共存、多重用药者使用他汀时,若出现肌痛、近端肌无力或吞咽困难,应警惕抗HMGCR肌病。
局限性
- 本文为单例病例报告,不能提供发生率、疗效或预后的一般化结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Statins are widely prescribed in the treatment of hypercholesterolemia. While their efficacy in the secondary prevention of vascular events is proven, their safety profile in older patients with multiple co-morbidities and polypharmacy remains questionable. Although rare, antihydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) myopathy is a severe adverse effect of statins, manifesting as myalgias, proximal muscle weakness, muscle cell necrosis and rhabdomyolysis. We report an uncommon case of an autopsy-proven anti-HMGCR necrotising myopathy predominately affecting pharyngeal muscles in an older patient, leading to dysphagia, pneumonia and death within 3 weeks from onset. Clinicians should screen for dysphagia in any patient with suspected anti-HMGCR myopathy, order an anti-HMGCR antibody titre and consider prompt immunosupressive therapy.
引用
- Mirlesse N, Egervari K, Bornand A, et al. Statin-induced autoimmune necrotizing myopathy with pharyngeal muscles involvement. Age Ageing. 2020. PMID: 32147707. doi:10.1093/ageing/afaa038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。